Please assess the completion status of the following clinical trial:

Trial Title: iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females (English or Spanish speaking) age ≥ 18 years with a history of AF in the last 30 days that was treated with normal rhythm restored.~* Ability to successfully use the AliveCor™ Heart Monitor, capture a baseline ECG, and transmit on the day of enrollment~* Demonstrated ability to receive, read, and send a text messages on the day of enrollment~* Willingness to complete the study questionnaires at baseline and 6 months~Exclusion Criteria:~* Documented permanent (chronic) AF~* Patient found to be in AF or other rhythm disturbances on the day of enrollment (i.e., they need to be clinically evaluated or treated)~* Unwillingness have their clinical data collected over the study period~* Unwillingness to receive and read cardiovascular text messaging three times a week.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- iHEART (Type: EXPERIMENTAL): Participants will transmit daily ECGs using AliveCor for 6 months following cardioversion or ablation procedure to treat AF/AFL. Participants will also receive read-only behavioral altering messaging three times per week focusing on AF, cardiovascular risk factors, and healthy living.
- Usual Care (Type: NO_INTERVENTION): Participants will continue with usual care with their physician.

Based on this trial design, predict the completion outcome and termination type (if applicable).